v3.26.3
Segment Information (Tables)
9 Months Ended
Sep. 30, 2026
Single Reportable Segment [Member]  
Segment Reporting [Line Items]  
Summary Of Additional Information On Company's Net loss Including Segment Expenses

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Research and development expense

 

 

 

 

 

 

 

 

 

 

 

LX2006

$

12,660

 

 

$

5,135

 

 

$

26,104

 

 

$

12,072

 

LX2020

 

2,746

 

 

 

3,137

 

 

 

5,753

 

 

 

12,058

 

Other programs

 

1,569

 

 

 

845

 

 

 

4,334

 

 

 

2,192

 

Employee compensation expenses

 

3,847

 

 

 

3,374

 

 

 

11,703

 

 

 

11,833

 

Lab-related costs and supplies

 

558

 

 

 

449

 

 

 

1,553

 

 

 

1,128

 

Acquired in-process research and development

 

9,874

 

 

 

-

 

 

 

9,874

 

 

 

-

 

All other research and development expense

 

3,242

 

 

 

2,755

 

 

 

9,905

 

 

 

8,304

 

General and administrative expense

 

 

 

 

 

 

 

 

 

 

 

Employee compensation expenses

 

2,165

 

 

 

1,867

 

 

 

6,124

 

 

 

6,156

 

All other general and administrative expense

 

3,738

 

 

 

4,086

 

 

 

15,402

 

 

 

32,398

 

Other income and expense, net

 

(2,099

)

 

 

(1,365

)

 

 

(6,389

)

 

 

(7,099

)

Net loss

$

(38,300

)

 

$

(20,283

)

 

$

(84,363

)

 

$

(79,042

)